Treace Medical Concepts 

$1.45
13
+$0.04+2.84% Thursday 20:00

Statistics

Day High
1.46
Day Low
1.32
52W High
8.13
52W Low
1.17
Volume
331,316
Avg. Volume
747,908
Mkt Cap
92.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.31
-0.21
-0.11
-0.01
Expected EPS
-0.308
Actual EPS
N/A

Financials

-26.63%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
418.71MRevenue
-111.49MNet Income

Analyst Ratings

$4.77Average Price Target
The highest estimate is 7.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
17%
Hold
67%
Sell
17%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TMCI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a direct competitor in the medical technology and orthopedic devices sector, offering products that can compete with Treace Medical Concepts' foot and ankle surgery solutions.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, competing in the orthopedic market with products that could be used in similar procedures as those targeted by Treace Medical Concepts.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers a wide range of medical technologies, including orthopedic solutions that compete with Treace Medical Concepts' offerings in the surgical space.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson's medical devices segment, particularly its DePuy Synthes brand, provides orthopedic and other surgical products that compete with Treace Medical Concepts' portfolio.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. designs, develops, and commercializes musculoskeletal solutions, which puts it in direct competition with Treace Medical Concepts in the orthopedic surgery market.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew plc offers advanced medical devices in orthopedics, among other areas, competing with Treace Medical Concepts in the global market for surgical solutions.
Alphatec
ATEC
Mkt Cap2.87B
Alphatec Holdings, Inc. is primarily focused on spine surgery solutions but competes in the broader orthopedic sector, including areas that overlap with Treace Medical Concepts' focus.
K2 Capital Acquisition
KTWO
Mkt Cap0
K2M Group Holdings, Inc., before its acquisition by Stryker, specialized in innovative spine and minimally invasive solutions, competing in the orthopedic space with Treace Medical Concepts.

About

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Show more...
CEO
Mr. John T. Treace
Employees
477
Country
US
ISIN
US89455T1097

Listings

0 Comments

Share your thoughts

FAQ

What is Treace Medical Concepts stock price today?
The current price of TMCI is $1.45 USD — it has increased by +2.84% in the past 24 hours. Watch Treace Medical Concepts stock price performance more closely on the chart.
What is Treace Medical Concepts stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Treace Medical Concepts stocks are traded under the ticker TMCI.
Is Treace Medical Concepts stock price growing?
TMCI stock has risen by +18.85% compared to the previous week, the month change is a -1.36% fall, over the last year Treace Medical Concepts has showed a -81.29% decrease.
What is Treace Medical Concepts market cap?
Today Treace Medical Concepts has the market capitalization of 92.39M
When is the next Treace Medical Concepts earnings date?
Treace Medical Concepts is going to release the next earnings report on May 13, 2026.
What were Treace Medical Concepts earnings last quarter?
TMCI earnings for the last quarter are -0.15 USD per share, whereas the estimation was -0.15 USD resulting in a +1.25% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Treace Medical Concepts revenue for the last year?
Treace Medical Concepts revenue for the last year amounts to 418.71M USD.
What is Treace Medical Concepts net income for the last year?
TMCI net income for the last year is -111.49M USD.
How many employees does Treace Medical Concepts have?
As of April 04, 2026, the company has 477 employees.
In which sector is Treace Medical Concepts located?
Treace Medical Concepts operates in the Health Care sector.
When did Treace Medical Concepts complete a stock split?
Treace Medical Concepts has not had any recent stock splits.
Where is Treace Medical Concepts headquartered?
Treace Medical Concepts is headquartered in Ponte Vedra, US.